- 英文名称
- Levofloxacin
- 分子式
- C18H20FN3O4
- 分子量
- 361.37
- 中文别名
- (-)9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶骈[1,2,3-DE]-[1,4]苯骈噁嗪-6-羧酸; 洛氟沙星(兽用); 洛氟沙星; 左旋氧氟沙星; S-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧代-7H-吡啶[1,2,3-DE]-1,4-苯并噁嗪-6-羧酸半水合物; 利复星; 左氟沙星; (S)-9-氟-3-甲基-10-(4-甲基哌嗪-1-基)-7-氧代-3,7-二氢-2H-[1,4]恶嗪并[2,3,4-ij]喹啉-6-羧酸; (-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶骈[1,2,3-DE]-[1,4]苯骈噁嗪-6-羧酸; (s)-ofloxacin; 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-; Cravit; HR 355; Levaquin; RWJ 25213-097; Tavanic; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; l-ofloxacin; rwj 25213; lvfx; (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; (3S)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; S-(-)-Ofloxacin; levoflaxacin; (3S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- 用途
- 作为全合成抗菌素，用于治疗呼吸道、泌尿道和皮肤组织感染等多种细菌感染，可制成口服或注射剂，用于社区获得性肺炎、细菌性鼻窦炎等适应症，通过抑制细菌DNA旋转酶阻止DNA合成复制导致细菌死亡。
